Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-007157-31Phase 2Completed
Phase 2 trial of Fibrinogen human in coronary arteriosclerosis and perioperative bleeding, sponsored by Sahlgrenska University Hospital. Primary endpoint: Number of transfusions with blood products during hospital stay. Started Feb 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-007157-31.